Clinical Trial Detail

NCT ID NCT03919071
Title Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

ganglioglioma

pleomorphic xanthoastrocytoma

malignant glioma

glioblastoma multiforme

astrocytoma

Therapies

Dabrafenib + Trametinib

Age Groups: adult child

Additional content available in CKB BOOST